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Abstract
Objective: We explored whether medical health workers 
had more psychosocial problems than nonmedical health 
workers during the COVID-19 outbreak. Methods: An online 
survey was run from February 19 to March 6, 2020; a total of 
2,182 Chinese subjects participated. Mental health variables 
were assessed via the Insomnia Severity Index (ISI), the 
Symptom Check List-revised (SCL-90-R), and the Patient 
Health Questionnaire-4 (PHQ-4), which included a 2-item 
anxiety scale and a 2-item depression scale (PHQ-2). Results: 
Compared with nonmedical health workers (n = 1,255), med-
ical health workers (n = 927) had a higher prevalence of in-
somnia (38.4 vs. 30.5%, p < 0.01), anxiety (13.0 vs. 8.5%, p < 
0.01), depression (12.2 vs. 9.5%; p < 0.04), somatization (1.6 
vs. 0.4%; p < 0.01), and obsessive-compulsive symptoms (5.3 
vs. 2.2%; p < 0.01). They also had higher total scores of ISI, 
GAD-2, PHQ-2, and SCL-90-R obsessive-compulsive symp-
toms (p ≤ 0.01). Among medical health workers, having or-
ganic disease was an independent factor for insomnia, anxi-
ety, depression, somatization, and obsessive-compulsive 
symptoms (p < 0.05 or 0.01). Living in rural areas, being fe-
male, and being at risk of contact with COVID-19 patients 
were the most common risk factors for insomnia, anxiety, 
obsessive-compulsive symptoms, and depression (p < 0.01 
or 0.05). Among nonmedical health workers, having organic 
disease was a risk factor for insomnia, depression, and obses-
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sive-compulsive symptoms (p < 0.01 or 0.05). Conclusions: 
During the COVID-19 outbreak, medical health workers had 
psychosocial problems and risk factors for developing them. 
They were in need of attention and recovery programs.
© 2020 S. Karger AG, Basel
Introduction
The coronavirus disease 2019 (COVID-19) outbreak 
is a pandemic [1] in which a coronavirus has been identi-
fied as the cause of an outbreak of respiratory illness. It 
was first detected in Wuhan, China [2], but COVID-19 is 
becoming an increasing public event being a rapid epi-
demic [3, 4]. According to the official website of the 
World Health Organization [5], as of March 7, 2020, 
more than 100,000 people have been confirmed to have a 
COVID-19 infection globally. Many accomplishments 
on COVID-19, including virus information, clinical fea-
tures, and diagnosis have been achieved, but no effective 
treatment is available yet [2, 6–8]. 
Medical health workers are first-line fighters treating 
patients with COVID-19. Every day, they face a high risk 
of being infected and are exposed to long and distressing 
work shifts to meet health requirements. In brief, they are 
exposed to a protracted source of distress which may ex-
ceed their individual coping skills, being, according to a 
clinimetric definition [9], in allostatic load, which is like-
ly to result in overload with protracted time [9].
Despite messages mentioning that medical health 
workers’ mental health should be emphasized during the 
campaign against COVID-19 [10–12], no research on 
mental health problems in medical health workers after 
the maximum point of the COVID-19 epidemic in China 
has been reported. 
Since Chinese medical health workers have been ex-
posed to a persistent source of distress, the aim of the 
present research was to outline its psychological manifes-
tations. For this purpose, the prevalence and potential 
factors contributing to insomnia, anxiety, depression, ob-
sessive-compulsive symptoms, somatization symptoms, 
and phobic anxiety were detected.
Materials and Methods
Design, Participants, and Procedure
This is a cross-sectional study performed via an online survey 
run from February 19 to March 6, 2020. The study was performed 
8 weeks after the COVID-19 epidemic outbreak in Wuhan [2]. 
This survey period corresponded to the reducing stage after the 
maximum point of the COVID-19 epidemic outbreak in China 
[13], i.e., the highest vulnerability period after the great distress. 
Persons in the nation with at least 16 years of age were welcome 
to join in the online survey via the Wenjuanxing platform (https://
www.wjx.cn/m/58475441.aspx). 
The online survey included questions on sociodemographic 
and clinical variables. A simple math question (i.e., 21–7 = ?) was 
added at the end for ensuring the quality and completeness of the 
questionnaire. Thus, participants who had not completed the sur-
vey received from the online platform a warning on unanswered 
questions when they did the math question. The online platform 
did not give warnings to those who gave up. As a result, partici-
pants were those who completed all questions of the online survey.
Measurements
Demographic data, i.e., sex, age, occupation (medical health 
workers, i.e., medical doctors and nurses, and nonmedical health 
workers, excluding nonmedical personnel working in hospitals/
medical institutions), marital status (i.e., married, unmarried, di-
vorced, and widowed), living area (i.e., urban and rural), living 
with families (yes or no), education status (≤9 years, i.e. junior 
high school and lower, > 9 years, i.e. senior high school and higher) 
were collected via ad hoc questions as well as the information of a 
risk of contact with COVID-19 patients in hospitals. Participants 
were also asked whether they have had insomnia or psychiatric 
disorders prior to COVID-19 (those who replied positively were 
automatically excluded by the platform) and whether they were 
having organic diseases (the question was “Do you currently have 
any organic disease? [diagnosed by medical examination in the 
hospital]”). In addition, insomnia, anxiety, depression, somatiza-
tion, obsessive-compulsive symptoms, and phobic anxiety were 
assessed. 
Insomnia was assessed via the Insomnia Severity Index (ISI), a 
7-item self-report index assessing the severity of initial, middle, 
and late insomnia [14]. An ISI total score > 8 indicates that insom-
nia is present [15]. The item “Since the outbreak, how long (in 
minutes) did you usually take to fall asleep each night?” was added 
to assess the degree of sleep onset latency in medical health work-
ers. This item was rated as 0, 1, 2, and 3 (i.e., ≤15, 16–30, 31–60, 
and > 60 min, respectively). 
Anxious and depressive symptoms were assessed via the Pa-
tient Health Questionnaire-4 (PHQ-4) [16], which is an ultra-brief 
self-report questionnaire with a 2-item anxiety scale, named Gen-
eralized Anxiety Disorder 2-item (GAD-2), and a 2-item depres-
sion scale, named Patient Health Questionnaire 2-item (PHQ-2). 
In screening of depression and anxiety, a cutoff ≥3 in GAD-2 and 
PHQ-2 is recommended [16]. 
Somatic symptoms, obsessive-compulsive symptoms, and 
phobic anxiety were measured via the Symptom Check List-90- 
revised (SCL-90-R) [17, 18], a 90-item self-report scale with items 
rated on a 5-point Likert scale (from 0 “not at all” to 4 “extremely”). 
Subscale scores ≥2 indicate potential psychological issues [19].
The Chinese versions of ISI [20], PHQ-2 [21], GAD-2 [22], and 
SCL-90-R [18] were used; they were validated and showed excel-
lent psychometric properties. 
Statistical Analyses
χ2 tests were used to compare group differences of categorical 
variables. Mann-Whitney tests were used to compare independent 
groups on continuous variables nonnormally distributed. 
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Sex, % (n) <0.01
Male 35.8 (781) 26.9 (249) 42.4 (532)
Female 64.2 (1,401) 73.1 (678) 57.6 (723)
Age, % (n) <0.01
<18 years 0.5 (11) 0.2 (2) 0.7 (9)
18–60 years 96.3 (2,101) 98.4 (912) 94.7 (1,189)
>60 years 3.2 (70) 1.4 (13) 4.5 (57)
Marital status, % (n) 0.70
Single 18.0 (392) 18.3 (170) 17.7 (222)
Married 82.0 (1,790) 81.7 (757) 82.3 (1,033)
Living areas, % (n) <0.01
Urban 84.8 (1,851) 89.2 (827) 81.6 (1,024)
Rural 15.2 (331) 10.8 (100) 18.4 (231)
Living with families, % (n) <0.01
No 12.0 (262) 16.4 (152) 8.8 (110)
Yes 88.0 (1,920) 83.6 (775) 91.2 (1,145)
Education, % (n) <0.01
≤9 years 5.5 (120) 0.3 (3) 9.3 (117)
>9 years 94.5 (2,062) 99.7 (924) 90.7 (1,138)
Risk of contact with COVID-19 patients in hospitals, % (n) –
No – 85.1 (789) –
Yes – 14.9 (138) –
Having organic diseases, % (n) 0.78
No 89.0 (1,942) 88.8 (823) 89.2 (1,119)
Yes 11.0 (240) 11.2 (104) 10.8 (136)
Insomnia Severity Index (ISI), % (n) <0.01
No clinically significant insomnia (total ISI score: 0–7) 66.1 (1,443) 61.6 (571) 69.5 (872)
Subthreshold insomnia (total ISI score: 8–14) 24.3 (531) 27.8 (258) 21.8 (273)
Moderate insomnia (total ISI score: 15–21) 8.1 (177) 8.8 (82) 7.6 (95)
Severe insomnia (total ISI score: 22–28) 1.4 (31) 1.7 (16) 1.2 (15)
Insomnia, % (n) <0.01
No 66.1 (1,443) 61.6 (571) 69.5 (872)
Yes 33.9 (739) 38.4 (356) 30.5 (383)
Anxiety, % (n) <0.01
No 89.6 (1,954) 87.0 (806) 91.5 (1,148)
Yes 10.4 (228) 13.0 (121) 8.5 (107)
Depression, % (n) 0.04
No 89.4 (1,950) 87.8 (814) 90.5 (1,136)
Yes 10.6 (232) 12.2 (113) 9.5 (119)
Somatization symptoms, % (n) <0.01
No 99.1 (2,162) 98.4 (912) 99.6 (1,250)
Yes 0.9 (20) 1.6 (15) 0.4 (5)
Obsessive-compulsive symptoms, % (n) <0.01
No 96.5 (2,105) 94.7 (878) 97.8 (1,227)
Yes  3.5 (77) 5.3 (49) 2.2 (28)
Phobic anxiety, % (n) 0.11
No 97.1 (2,119) 96.4 (894) 97.6 (1,225)
Yes 2.9 (63) 3.6 (33) 2.4 (30)
COVID-19, the coronavirus disease 2019.
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Multivariate logistic regression analyses were performed using 
stepwise variable selection, and all variables were entered into the 
model to explore independent influence for different risk dimen-
sions, such as insomnia, anxiety, depression, somatization, obses-
sive-compulsive symptoms, and phobic anxiety. Subgroup analy-
ses were performed for medical and nonmedical health workers. 
All hypotheses were tested at a significance level of 0.05. 
Data analyses were run via SAS statistical software, version 9.4 
(SAS Institute Inc.).
Results
Nationwide, a total of 2,182 participants from China 
(see online supplement 1; for all online suppl. material, 
see www.karger.com/doi/10.1159/000507639) complet-
ed the survey.
Table 1 presents sociodemographic features of the whole 
sample and compared 927 medical health workers (680 
medical doctors and 247 nurses) to 1,255 nonmedical health 
workers. Medical health workers showed higher prevalence 
rates of insomnia (38.4 vs. 30.5%, p < 0.01), anxiety (13.0 vs. 
8.5%, p < 0.01), depression (12.2 vs. 9.5%; p = 0.04), soma-
tization (1.6 vs. 0.4%; p < 0.01), and obsessive-compulsive 
symptoms (5.3 vs. 2.2%; p < 0.01) than nonmedical health 
workers. Medical health workers also had higher total 
scores of ISI (p < 0.01), GAD-2 (p < 0.01), PHQ-2 (p = 0.01), 
and on the SCL-90-R obsessive-compulsive symptom scale 
(p < 0.01) than nonmedical health workers. Each item of ISI 
(p < 0.01 or p < 0.05), GAD-2 (p < 0.01), and PHQ-2 (p = 
0.01) was significantly elevated in medical health workers 
compared with nonmedical health workers. On the SCL-
90-R obsessive-compulsive symptom scale, 6 of the 10 items 
had higher scores in medical health workers than in non-
medical health workers. In the SCL-90-R somatization 
symptoms scale, 3 of 12 items, including questions 1 (head-
aches) (p = 0.01), 4 (faintness or dizziness) (p < 0.01), and 
48 (trouble getting your breath) (p < 0.01), had higher scores 
in medical health workers than in nonmedical health work-
ers. No difference on phobic anxiety between both groups 
was found (Table 2).
The multivariate logistic regression analyses (Table 3) 
showed that living in rural areas (odds ratio [OR], 2.18, 
95% confidence interval [CI], 1.42–3.35; p < 0.01), being 
at risk of contact with COVID-19 patients in hospitals 
(OR, 2.53; 95% CI, 1.74–3.68; p < 0.01), and having or-
ganic diseases (OR, 3.39; 95% CI, 2.20–5.22; p < 0.01) 
were risk factors for insomnia among medical health 
workers, while only having organic diseases (OR, 2.23; 
95% CI, 1.55–3.20; p < 0.01) was a risk factor for the non-
medical health workers. 
Four variables were independently associated with 
anxiety risk among medical health workers: being female 
(OR, 1.80, 95% CI, 1.10–2.95; p = 0.02), living in rural ar-
eas (OR, 1.88; 95% CI, 1.09–3.21; p = 0.02), being at risk 
of contact with COVID-19 patients in hospitals (OR, 
2.06; 95% CI, 1.28–3.32; p < 0.01), and having organic 
diseases (OR, 2.85; 95% CI, 1.73–4.68; p < 0.01). 
In depression models, being female (OR, 1.85, 95% CI, 
1.11–3.08; p = 0.02) and having organic diseases (OR, 
2.51; 95% CI, 1.51–4.18; p < 0.01) were selected as inde-
pendent factors among medical health workers, while 
having organic diseases (OR, 1.90; 95% CI, 1.13–3.20; p < 
0.01) and living with families (OR, 0.36; 95% CI, 0.21–
0.59; p < 0.01) were predictors for depression among non-
medical health workers. 
For obsessive-compulsive symptoms, medical health 
workers had 3 risk factors: living in rural areas (OR, 2.49; 
95% CI, 1.21–5.11; p = 0.01), being at risk of contact with 
COVID-19 patients in hospitals (OR, 3.27; 95% CI, 1.75–
6.11; p < 0.01), and having organic diseases (OR, 2.24; 
95% CI, 1.07–4.71; p = 0.03). On the other hand, non-
medical health workers had organic diseases (OR, 2.84; 
95% CI, 1.18–6.80; p = 0.02) as only risk factor. 
Regarding somatization symptoms, medical health 
workers had 2 risk factors: living in rural areas (OR, 4.78; 
95% CI, 1.55–14.76; p = 0.01) and having organic diseas-
es (OR, 7.89; 95% CI, 2.75–22.62; p < 0.01). No risk factors 
were found for nonmedical health workers.
Discussion
Medical health workers during the COVID-19 epidem-
ic had high prevalence rates of severe insomnia, anxiety, 
depression, somatization, and obsessive-compulsive 
symptoms. They also had risk factors for developing in-
somnia, anxiety, depression, obsessive-compulsive symp-
toms, and somatization. Thus, the presence of these symp-
toms in addition to the life status of daily fighting against 
COVID-19 suggests that they must cope with psychologi-
cal distress and are at risk of allostatic overload [9]. Indeed, 
according to clinimetric criteria, allostatic overload can be 
diagnosed in the presence of a current identifiable source 
of distress in the form of recent life events and/or chronic 
stress; the stressor is judged to tax or exceed the individual 
coping skills when its full nature and full circumstances are 
evaluated. In addition, the stressor is associated with dif-
ficulty in falling asleep, restless sleep, early morning awak-
ening, lack of energy, dizziness, generalized anxiety, irrita-
bility, sadness, demoralization; significant impairment in 
COVID-19 Epidemic: Psychosocial 
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Sleep onset latency (score) 1.27±1.01 1.33±1.00 1.22±1.01 <0.01
Insomnia Severity Index (ISI) total score 6.17±5.65 6.70±5.76 5.78±5.55 <0.01
Item 1: Falling asleep 0.91±0.97 0.96±0.95 0.87±0.98 0.01
Item 2: Staying asleep 0.74±0.89 0.86±0.90 0.65±0.87 <0.01
Item 3: Early awakening 0.59±0.85 0.66±0.88 0.55±0.83 <0.01
Item 4: Satisfaction 1.47±1.02 1.57±1.02 1.40±1.00 <0.01
Item 5: Interfere 0.74±0.94 0.82±0.97 0.67±0.91 <0.01
Item 6: Noticeable 0.93±1.01 0.98±1.00 0.90±1.01 0.02
Item 7: Worried 0.79±0.96 0.86±0.98 0.74±0.94 <0.01
Total GAD-2 score (items 1, 2 of PHQ-4) 1.36±1.25 1.51±1.28 1.25±1.23 <0.01
Item 1: Feeling nervous/anxious/on edge 0.83±0.70 0.91±0.70 0.76±0.70 <0.01
Item 2: Not being able to stop worrying 0.53±0.66 0.59±0.69 0.48±0.63 <0.01
Total PHQ-2 score (items 3, 4 of PHQ-4) 1.25±1.32 1.35±1.37 1.18±1.28 0.01
Item 3: Feeling down/depressed/hopeless 0.64±0.73 0.69±0.75 0.60±0.72 0.01
Item 4: Little interest in doing things 0.61±0.70 0.66±0.72 0.58±0.68 0.01
Total somatization symptoms score 3.22±4.88 3.46±5.39 3.04±4.46 0.70
Question 1: Headaches 0.44±0.74 0.51±0.82 0.40±0.67 0.01
Question 4: Faintness or dizziness 0.21±0.52 0.26±0.59 0.18±0.46 <0.01
Question 12: Pain in the heart or chest 0.20±0.53 0.22±0.56 0.19±0.50 0.35
Question 27: Pain in the lower back 0.48±0.80 0.50±0.83 0.46±0.78 0.64
Question 40: Nausea or upset stomach 0.24±0.54 0.25±0.58 0.23±0.52 0.62
Question 42: Soreness of your muscles 0.41±0.71 0.41±0.73 0.41±0.70 0.64
Question 48: Trouble getting your breath 0.17±0.46 0.20±0.50 0.14±0.42 <0.01
Question 49: Hot or cold spells 0.19±0.47 0.21±0.51 0.17±0.44 0.05
Question 52: Numbness/tingling in body 0.17±0.47 0.15±0.45 0.17±0.48 0.32
Question 53: A lump in your throat 0.23±0.54 0.25±0.57 0.21±0.52 0.14
Question 56: Feeling weak in your body 0.28±0.58 0.29±0.61 0.27±0.57 0.91
Question 58: Heavy feelings in arms/legs 0.21±0.53 0.21±0.55 0.21±0.52 0.87
Total obsessive-compulsive symptom score 5.43±5.99 6.02±6.55 4.99±5.50 <0.01
Question 3: Unwanted thoughts/words 0.57±0.77 0.58±0.80 0.56±0.75 0.81
Question 9: Trouble remembering things 0.56±0.81 0.58±0.83 0.54±0.79 0.28
Question 10: Worried about sloppiness 0.29±0.60 0.37±0.68 0.24±0.52 <0.01
Question 28: Feeling blocked 0.52±0.82 0.56±0.85 0.50±0.80 0.20
Question 38: Having to do very slowly 0.47±0.76 0.54±0.79 0.43±0.72 <0.01
Question 45: Check and double-check 0.55±0.82 0.67±0.90 0.47±0.74 <0.01
Question 46: Difficulty making decisions 0.41±0.72 0.47±0.77 0.36±0.67 <0.01
Question 51: Your mind going blank 0.48±0.84 0.50±0.85 0.47±0.83 0.45
Question 55: Trouble concentrating 0.49±0.82 0.54±0.85 0.46±0.80 0.02
Question 65: Having to repeat 1.07±1.07 1.22±1.13 0.96±1.00 <0.01
Total phobic anxiety score 3.72±4.05 3.78±4.18 3.68±3.96 0.87
Question 13: Afraid in open space 0.16±0.46 0.17±0.46 0.16±0.46 0.63
Question 25: Afraid to go out alone 0.17±0.50 0.15±0.46 0.17±0.52 0.68
Question 47: Afraid to travel 0.99±1.15 0.99±1.14 0.99±1.15 0.99
Question 50: Having to avoid the certain 0.97±1.06 0.94±1.05 0.98±1.07 0.47
Question 70: Feeling uneasy in crowds 1.05±1.19 1.07±1.18 1.03±1.21 0.16
Question 75: Nervous when left alone 0.22±0.57 0.25±0.63 0.19±0.51 0.05
Question 82: Afraid to faint in public 0.17±0.56 0.20±0.62 0.15±0.51 0.13
GAD-2, Generalized Anxiety Disorder 2-item; PHQ-4, Patient Health Questionnaire-4; PHQ-2, Patient Health Questionnaire 2 
items. Mann-Whitney test for independent samples.
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Table 3. Outcomes of psychological manifestations
Variables OR (95% CI) p value
Models for insomnia
MHWs
Living areas (rural vs. urban) 2.18 (1.42, 3.35) <0.01
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 2.53 (1.74, 3.68) <0.01
Having organic diseases (yes vs. no) 3.39 (2.20, 5.22) <0.01
NMHWs
Having organic diseases (yes vs. no) 2.23 (1.55, 3.20) <0.01
Total population
Living areas (rural vs. urban) 1.38 (1.08, 1.77) 0.01
Occupation (MHWs vs. NMHWs) 1.24 (1.02, 1.50) 0.03
Living with families (yes vs. no) 0.68 (0.52, 0.89) 0.01
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 2.45 (1.68, 3.56) <0.01
Having organic diseases (yes vs. no) 2.69 (2.05, 3.55) <0.01
Models for anxiety
MHWs
Sex (female vs. male) 1.80 (1.10, 2.95) 0.02
Living areas (rural vs. urban) 1.88 (1.09, 3.21) 0.02
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 2.06 (1.28, 3.32) <0.01
Having organic diseases (yes vs. no) 2.85 (1.73, 4.68) <0.01
NMHWs
No variables were entered – –
Total population
Sex (female vs. male) 1.69 (1.24, 2.32) <0.01
Marital status (married vs. single) 1.56 (1.03, 2.35) 0.04
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 2.47 (1.59, 3.83) 0.05
Having organic diseases (yes vs. no) 2.09 (1.45, 3.00) <0.01
Models for depression
MHWs
Sex (female vs. male) 1.85 (1.11, 3.08) 0.02
Having organic diseases (yes vs. no) 2.51 (1.51, 4.18) <0.01
NMHWs
Living with families (yes vs. no) 0.36 (0.21, 0.59) <0.01
Having organic diseases (yes vs. no) 1.90 (1.13, 3.20) 0.02
Total population
Living areas (rural vs. urban) 1.46 (1.03, 2.07) 0.04
Living with families (yes vs. no) 0.52 (0.36, 0.74) <0.01
Having organic diseases (yes vs. no) 2.17 (1.51, 3.12) <0.01
Models for somatization symptoms
MHWs
Living areas (rural vs. urban) 4.78 (1.55, 14.76) <0.01
Having organic diseases (yes vs. no) 7.89 (2.75, 22.62) <0.01
NMHWs
No variables were entered – –
Total population
Living areas (rural vs. urban) 3.30 (1.22, 8.93) 0.02
Occupation (MHWs vs. NMHWs) 4.70 (1.67, 13.22) <0.01
Having organic diseases (yes vs. no) 7.14 (2.90, 17.60) <0.01
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social or occupational functioning; and feeling over-
whelmed by the demands of everyday life [9].
The reasons for the psychological distress to which 
medical health workers were exposed might be related to 
the many difficulties of being safe at work, such as the 
initially insufficient understanding of the virus, the lack 
of prevention and control knowledge, the long-term 
workload, the high risk of exposure to patients with 
COVID-19, the shortage of medical protective equip-
ment [13, 23], the lack of getting rest [24], and the expo-
sure to critical life events [25], such as death. Exemplifica-
tions of such a distress are: (1) 16 of the 100 nurses at the 
Pohang Medical Center in North Gyeongsang Province 
resigned due to overwork among the COVID-19 epidem-
ic [26]; (2) > 3,000 medical health workers in (Wuhan) 
Hubei Province were infected with COVID-19 at a very 
early stage (before and in January of 2020). Later, with 
continuously updated guidelines on how to handle the 
patients with COVID-19 [27], with rest in shifts for med-
ical staff, with rapid supply of medical protective items 
(including masks, glasses, and suits), and with training on 
the Novel Coronavirus Infection Pneumonia Diagnosis 
and Treatment Plan for all medical staff [24], no doctors 
have been infected with COVID-19 among about 40,000 
medical personnel from the nation supporting Hubei 
medical services [24]; and (3) as of the 20th March, 5 
medical health workers  in one hospital of Wuhan died 
due to being infected with COVID-19 [28].
Our report found potential risk factors for medical 
health workers to develop insomnia, anxiety, depression, 
obsessive-compulsive symptoms, and somatization. Un-
doubtedly, these risk factors might endure allostatic over-
load and favor the development of psychopathology, in-
cluding chronic insomnia [29]. Independent factors (i.e., 
currently having organic disease, living in rural areas, be-
ing at risk of contact with COVID-19 patients in hospi-
tals, or being female) were common risk factors for in-
somnia, anxiety, depression, and obsessive-compulsive 
symptoms among medical health workers. When faced 
with the same COVID-19 during the fight against the ep-
idemic, medical health workers in rural areas might wor-
ry about being infected due to a different working place 
involving different medical skills and medical conditions. 
In contrast, the medical conditions in urban areas were 
often much better. Thus, different directions on caring 
for the medical health workers might be possible. 
Adequate working conditions and recovery programs, 
i.e., programs favoring activities required to ensure the 
best physical, mental, and social conditions so that medi-
cal workers may progress towards an optimal state of 
health [30], seem necessary. This may support medical 
staff in adapting to the working environment quickly and 
Variables OR (95% CI) p value
Models for obsessive-compulsive symptoms
MHWs
Living areas (rural vs. urban) 2.49 (1.21, 5.11) 0.01
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 3.27 (1.75, 6.11) <0.01
Having organic diseases (yes vs. no) 2.24 (1.07, 4.71) 0.03
NMHWs
Having organic diseases (yes vs. no) 2.84 (1.18, 6.80) 0.02
Total population
Occupation (MHWs vs. NMHWs) 1.85 (1.10, 3.10) 0.02
Risk of contact with COVID-19 patients in hospitals (yes vs. no) 3.38 (1.81, 6.29) <0.01
Having organic diseases (yes vs. no) 2.43 (1.38, 4.28) <0.01
Models for phobic anxiety
MHWs
No variables were entered – –
NMHWs
No variables were entered – –
Total population
Sex (female vs. male) 2.19 (1.18, 4.05) 0.01
OR, odds ratio; CI, confidence interval; MHWs, medical health workers; COVID-19, the coronavirus disease 2019; NMHWs, non-
MHWs. Multivariate logistic regression analyses using stepwise variable selection.
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maintain a better mental and health balance to be able to 
work. Lowering job demands and workload [31], while 
increasing job control and reward might help to protect 
medical health workers. Individual interventions ade-
quate for medical staff in the current situation, where they 
wear medical protective equipment which cannot be re-
moved during work time, are still unknown. Story shar-
ing [32] would be important as well as reinforcing the 
positive assets of persons [33]. Simple, easy, practical 
methods are needed. Electronic devices, such as mobile 
phones and computers, may help.
The present study has limitations. First, a cross-sec-
tional design was applied although a longitudinal ap-
proach might help verifying whether allostatic overload 
develops (exhaustion may ensue after some time) and 
whether psychiatric disorders, especially posttraumatic 
stress disorder, might occur with the COVID-19 progres-
sion. Second, psychological assessment was based on an 
online survey and on self-report tools. The use of clinical 
interviews is encouraged in future studies to draw a more 
comprehensive assessment of the problem. Third, it is not 
possible to assess the participation rate since it is unclear 
how many subjects received the link for the survey.
In conclusion, a higher prevalence of psychological 
symptoms was found among medical health workers dur-
ing COVID-19 as well as risk factors for them. Medical 
health workers are in need of health protection and ade-
quate working conditions, e.g., provision of necessary and 
sufficient medical protective equipment, arrangement of 
adequate rest, as well as recovery programs aimed at em-
powering resilience and psychological well-being [34].
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